Lapiz, Gemilyn B.

HRN: 21-51-55  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/04/2025
CEFTRIAXONE 1G (VIAL)
05/04/2025
05/19/2025
IV
2
Q12
Ex Lap Segmental Resection
Rejected 

 Indication:  ProphylaxisEmpiric    Type of Infection:  Intra-abdominal    Compliance to guidelines: Non-compliant To Guidelines